Michael Taylor
Direttore/Membro del Consiglio presso Deltex Medical Ltd.
Profilo
Michael Timmothy Taylor is currently a Director at Deltex Medical Ltd.
He previously worked as a Director-United Kingdom Sales at Deltex Medical Group Plc from 2002 to 2016.
Posizioni attive di Michael Taylor
Società | Posizione | Inizio |
---|---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Direttore/Membro del Consiglio | 12/01/2006 |
Precedenti posizioni note di Michael Taylor
Società | Posizione | Fine |
---|---|---|
DELTEX MEDICAL GROUP PLC | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
DELTEX MEDICAL GROUP PLC | Health Technology |
Aziende private | 1 |
---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Distribution Services |
- Borsa valori
- Insiders
- Michael Taylor